TABLE 01. GLOBAL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 02. GLOBAL ALPHA BLOCKERS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 03. GLOBAL 5-ALPHA REDUCTASE INHIBITORS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 04. GLOBAL PHOSPHODIESTERASE 5 INHIBITOR MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 05. GLOBAL OTHER BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. GLOBAL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 07. GLOBAL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET BY MONO DRUG THERAPY, BY REGION, 2017-2025 ($MILLION)
TABLE 08. GLOBAL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET BY COMBINATION DRUG THERAPY, BY REGION, 2017-2025 ($MILLION)
TABLE 09. GLOBAL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 11. U.S. BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 12. U.S. BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 13. CANADA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 14. CANADA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 15. MEXICO BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 16. MEXICO BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 17. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 18. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 19. EUROPE BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 20. GERMANY BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 21. GERMANY BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 22. FRANCE BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 23. FRANCE BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 24. UK BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 25. UK BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 26. ITALY BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 27. ITALY BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 28. SPAIN BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 29. SPAIN BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 30. REST OF EUROPE BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 31. REST OF EUROPE BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 32. EUROPE BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 33. EUROPE BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 34. ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 35. JAPAN BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 36. JAPAN BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 37. CHINA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 38. CHINA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 39. INDIA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 40. INDIA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 41. AUSTRALIA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 42. AUSTRALIA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 43. SOUTH KOREA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 44. SOUTH KOREA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 45. REST OF ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 46. REST OF ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 47. ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 48. ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 49. LAMEA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 50. BRAZIL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 51. BRAZIL BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 52. SAUDI ARABIA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 53. SAUDI ARABIA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 54. SOUTH ARICA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 55. SOUTH ARICA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 56. REST OF LAMEA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 57. REST OF LAMEA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 58. LAMEA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPEUTIC CLASS, 2017-2025 ($MILLION)
TABLE 59. LAMEA BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY THERAPY, 2017-2025 ($MILLION)
TABLE 60. ABBOTT: COMPANY SNAPSHOT
TABLE 61. ABBOTT: OPERATING SEGMENTS
TABLE 62. ABBOTT: PRODUCT PORTFOLIO
TABLE 63. ALLERGAN: COMPANY SNAPSHOT
TABLE 64. ALLERGAN: OPERATING SEGMENTS
TABLE 65. ALLERGAN: PRODUCT PORTFOLIO
TABLE 66. ASTELLAS: COMPANY SNAPSHOT
TABLE 67. ASTELLAS: PRODUCTS AND SERVICES
TABLE 68. ASTELLAS: PRODUCT PORTFOLIO
TABLE 69. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 70. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 71. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 72. LILLY: COMPANY SNAPSHOT
TABLE 73. LILLY: OPERATING SEGMENTS
TABLE 74. LILLY: PRODUCT PORTFOLIO
TABLE 75. GSK: COMPANY SNAPSHOT
TABLE 76. GSK: OPERATING SEGMENTS
TABLE 77. GSK: PRODUCT PORTFOLIO
TABLE 78. MERCK: COMPANY SNAPSHOT
TABLE 79. MERCK: OPERATING SEGMENTS
TABLE 80. MERCK: PRODUCT PORTFOLIO
TABLE 81. PFIZER: COMPANY SNAPSHOT
TABLE 82. PFIZER: OPERATING SEGMENTS
TABLE 83. PFIZER: PRODUCT PORTFOLIO
TABLE 84. SANOFI: COMPANY SNAPSHOT
TABLE 85. SANOFI: OPERATING SEGMENTS
TABLE 86. SANOFI: PRODUCT PORTFOLIO
TABLE 87. TEVA: COMPANY SNAPSHOT
TABLE 88. TEVA: OPERATING SEGMENTS
TABLE 89. TEVA: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 01. BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. BARGANING POWER OF BUYERS
FIGURE 05. BARGANING POWER OF SUPPLIERS
FIGURE 06. THREAT OF SUBSTITUTION
FIGURE 07. THREAT OF NEW ENTRANT
FIGURE 08. COMPETITIVE RIVALRY
FIGURE 09. IMPACT ANALYSES
FIGURE 10. CLINICAL TRIALS IN BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, BY REGION
FIGURE 11. CLINICAL TRIALS IN BPH THERAPEUTICS MARKET, NORTH AMERICA
FIGURE 12. COMPARATIVE ANALYSIS OF ALPHA BLOCKERS MARKET, 2017 & 2025 (PERCENTAGE)
FIGURE 13. COMPARATIVE ANALYSIS OF 5-ALPHA REDUCTASE INHIBITORS MARKET, 2017 & 2025 (PERCENTAGE)
FIGURE 14. COMPARATIVE ANALYSIS OF PHOSPHODIESTERASE 5 INHIBITOR MARKET, 2017 & 2025 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF OTHER BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET, 2017 & 2025 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET BY MONO DRUG THERAPY, 2017 & 2025 (PERCENTAGE)
FIGURE 17. COMPARATIVE ANALYSIS OF BENIGN PROSTATIC HYPERPLASIA THERAPEUTICS MARKET BY COMBINATION DRUG THERAPY, 2017 & 2025 (PERCENTAGE)
FIGURE 18. COMPARISON OF MALE GERIATRIC POPULATION IN EUROPEAN COUNTRIES FOR THE YEAR 2017, IN MILLION
FIGURE 19. ABBOTT: NET SALES, 2015-2017 ($MILLION)
FIGURE 20. ABBOTT: NET SALES SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 21. ABBOTT: NET SALES SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 22. ALLERGAN: REVENUE, 2015-2017 ($MILLION)
FIGURE 23. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 24. ASTELLAS: SALES, 2015-2017 ($MILLION)
FIGURE 25. ASTELLAS: SALES SHARE BY PRODUCTS AND SERVICES, 2017 (%)
FIGURE 26. ASTELLAS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 27. BOEHRINGER INGELHEIM: NET SALES, 2015-2017 ($MILLION)
FIGURE 28. BOEHRINGER INGELHEIM: NET SALES BY BUSINESS, 2017 (%)
FIGURE 29. BOEHRINGER INGELHEIM: NET SALES BY REGION, 2017 (%)
FIGURE 30. REVENUE, 2015-2017 ($MILLION)
FIGURE 31. LILLY: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 32. LILLY: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 33. GSK: REVENUE, 2015-2017 ($MILLION)
FIGURE 34. GSK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 35. GSK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 36. MERCK: NET SALES, 2015-2017 ($MILLION)
FIGURE 37. MERCK: NET SALES BY SEGMENT, 2017 (%)
FIGURE 38. MERCK: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 39. PFIZER: REVENUE, 2015-2017 ($MILLION)
FIGURE 40. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 41. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 42. SANOFI: NET SALES, 2015-2017 ($MILLION)
FIGURE 43. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 44. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 45. TEVA: REVENUE, 2015-2017 ($MILLION)
FIGURE 46. TEVA: REVENUE BY SEGMENT, 2017 (%)
FIGURE 47. TEVA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)